We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+19.09%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.27B
AUM Growth
-$5.76B
Cap. Flow
-$1.51B
Cap. Flow %
-46.09%
Top 10 Hldgs %
34.23%
Holding
5,681
New
749
Increased
1,274
Reduced
3,081
Closed
446

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Financials 8.46%
3 Healthcare 8.24%
4 Consumer Discretionary 7.74%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLOK icon
4476
Amplify Blockchain Technology ETF
BLOK
$1.05B
$7K ﹤0.01%
194
-6
-3% -$170
CEF icon
4477
Sprott Physical Gold and Silver Trust
CEF
$8.24B
$7K ﹤0.01%
364
CQP icon
4478
Cheniere Energy
CQP
$32.2B
$7K ﹤0.01%
206
CRON
4479
Cronos Group
CRON
$1.13B
$7K ﹤0.01%
949
-19,417
-95% -$134K
CVV icon
4480
CVD Equipment Corp
CVV
$54.6M
$7K ﹤0.01%
+1,981
New +$8.65K
DWX icon
4481
State Street SPDR S&P International Dividend ETF
DWX
$528M
$7K ﹤0.01%
200
EARN
4482
Ellington Residential Mortgage REIT
EARN
$164M
$7K ﹤0.01%
546
-8,191
-94% -$96.6K
ELSE
4483
DELISTED
Electro-Sensors
ELSE
$7K ﹤0.01%
1,455
-592
-29% -$2.42K
EPSN icon
4484
Epsilon Energy
EPSN
$179M
$7K ﹤0.01%
2,006
+1,063
+113% +$3.47K
ERNA icon
4485
Eterna Therapeutics
ERNA
$5.18M
0
FPAY
4486
DELISTED
FlexShopper
FPAY
$7K ﹤0.01%
2,896
+2,566
+778% +$4.95K
HFBL icon
4487
Home Federal Bancorp
HFBL
$7K ﹤0.01%
486
-760
-61% -$9.44K
HRMY icon
4488
Harmony Biosciences
HRMY
$2.3B
$7K ﹤0.01%
206
-3,034
-94% -$122K
AGIG
4489
Abundia Global Impact Group
AGIG
$39.2M
$7K ﹤0.01%
408
-139
-25% -$2.27K
INDY icon
4490
iShares S&P India Nifty 50 Index Fund
INDY
$565M
$7K ﹤0.01%
161
-24
-13% -$924
INUV icon
4491
Inuvo
INUV
$16.6M
$7K ﹤0.01%
+1,535
New +$5.9K
IYK icon
4492
iShares US Consumer Staples ETF
IYK
$1.43B
$7K ﹤0.01%
126
KINS icon
4493
Kingstone Companies
KINS
$276M
$7K ﹤0.01%
939
-31
-3% -$193
LAZR
4494
DELISTED
Luminar Technologies
LAZR
$7K ﹤0.01%
14
+8
+133% +$2.12K
LSTA icon
4495
Lisata Therapeutics
LSTA
$11.1M
$7K ﹤0.01%
331
-552
-63% -$13.1K
MBRX icon
4496
Moleculin Biotech
MBRX
$3.09M
$7K ﹤0.01%
+4
New +$7.1K
MCN
4497
Madison Covered Call & Equity Strategy Fund
MCN
$119M
$7K ﹤0.01%
+1,000
New +$6.3K
MIST icon
4498
Milestone Pharmaceuticals
MIST
$156M
$7K ﹤0.01%
1,096
+180
+20% +$1.21K
MNTS icon
4499
Momentus
MNTS
$90M
0
PAM icon
4500
Pampa Energía
PAM
$4.28B
$7K ﹤0.01%
506
+97
+24% +$1.25K

Similar funds

Tower Research Capital (TRC)'s Q4 2020 Portfolio in Review

As of Q4 2020, Tower Research Capital (TRC) held 5,681 positions worth $3.27B, down 64% from $9.03B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.51B in Q4 2020, closing 446 positions and reducing 3,081 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 6.3% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2020 buy was iShares Russell 1000 ETF: 115,321 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $99.8M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $36.3M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q4 2020, selling an estimated $13.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $3.27B portfolio in Q4 2020.
  • Tower Research Capital (TRC) opened 749 new positions and closed 446 in Q4 2020.
  • Tower Research Capital (TRC)'s portfolio value fell 64% quarter-over-quarter to $3.27B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.